Skip to main content
. 2022 Jul 5;49(13):4616–4641. doi: 10.1007/s00259-022-05870-1

Fig. 1.

Fig. 1

Targets in the TME suitable for radionuclide imaging and/or therapy. This includes altered TME processes and the EMC (left) and cellular components of the TME (right)